United States · FDA National Drug Code directory
Novolin R
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-3003_46700b71-3f26-4aaa-8eb7-6ceeeb515c79
- Product NDC
- 0169-3003
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Human Insulin
- Labeler
- Novo Nordisk
- Marketing category
- BLA
- Marketing start / end (source format)
- 20190906
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN HUMAN — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-01) · 0169-3003-15
- 5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-12) · 0169-3003-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →